Results 91 to 100 of about 645 (124)
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial
The Lancet Infectious DiseasesNorbert Heinrich, Christina Manyama, Simon E Koele, Stellah Mpagama, Francis Mhimbira, Modulakgotla Sebe, Robert S Wallis, Nyanda Ntinginya, Alphonce Liyoyo, Beno Huglin, Lilian Tina Minja, Larissa Wagnerberger, Krista Stoycheva, Tresphory Zumba, Ivan Noreña, Daud D Peter, Heeran Makkan, Derek J Sloan, Lindsey te Brake, Jodie Schildkraut, Rob E Aarnoutse, Timothy D McHugh, Leticia Wildner, Martin Boeree, Brian H Aldana, Patrick P J Phillips, Michael Hoelscher, Elin M Svensson, Michael Hoelscher, Julia Dreisbach, Larissa Wagnerberger, Norbert Heinrich, Alia Razid, Krista Stoycheva, Alexa Dierig, Anna Jarchow-MacDonald, Ivan Noreña, Laura Paramo Diaz, Rebekka Astudillo, Erlandy Basson, Anna-Lisa Behnke, Derek Sloan, Wilber Sabiiti, Stephen Gillespie, Lindsey te Brake, Elin Svensson, Chaima Mouhdad, Rob Aarnoutse, Martin Boeree, Ralf Stemkens, Simon Koele, Isabella van der Feltz, Anna Bateson, Robert Hunt, Timothy Daniel McHugh, Leticia Muraro Wildner, Priya Solanki, Patrick Phillips, Xue Gong, Brian Aldana, Angela Crook, Rodney Dawson, Kim Narunsky, Shakeera Arnolds, Andreas Diacon, Veronique de Jager, Ian Sanne, Mohammed Rassool, Gavin Churchyard, Modulakgotla Sebe, Heeran Makkan, Lucia Mokaba, Namhla Madikizela, John Mdluli, Jane Sithole, Robert Wallis, Trevor Beattie, Nyanda Elias Ntinginya, Chacha Mangu, Christina Manyama, Issa Sabi, Bariki Mtafya, Lilian Tina Minja, Ombeni Chimbe, Beatrice Ngaraguza, Francis Mhimbira, Benno Mbeya, Tresphory Zumba, Nyasige Chibunu, Mohamed Sasamalo, Klaus Reither, Levan Jugheli, Gibson Kibiki, Hadija Semvua, Stellah Mpagama, Alphonce Liyoyo, Bayode Romeo Adegbite, Ayola Akim Adegnika, Martin Peter Grobusch, Bruce Kirenga, Celso Khosa, Isabel Timana, Marriott Nliwasa, Madalo Mukoka +103 moreopenaire +1 more sourcePredicting tuberculosis drug efficacy in preclinical and clinical models from <i>in vitro</i> data. [PDF]
iScienceGoh JJN, Patel A, Ngara B, van Wijk RC, Strydom N, Wang Q, Van N, Washington TM, Nuermberger EL, Aldridge BB, Roubert C, Sarathy J, Dartois V, Savic RM. +13 moreeuropepmc +1 more sourcepanTB-HM: a clinical trial of a pan-TB regimen targeting both host and microbe
Mudzengi D, Mashatole S, Xiang Q, Adrion C, Glover N, Ngwanto T, Mdluli J, Boniface S, Rassool M, Paramo L, Svensson E, Fasanmi A, Angelo S, Moyo M, Marx C, Khosa C, Mofokeng N, Lalashowi J, Nacy C, Charalambous S, Fumane E, Maphossa V, Beattie T, Brumskine W, Venter C, Mapamba D, Heinrich N, Rajaram S, Kooverjee S, Nell M, Easton A, Foraida S, Ntinginya N, Wallis R. +33 moreeuropepmc +1 more sourceDeciphering linezolid-induced hematologic toxicity: Targeting TOP2A and TOP2B via its primary metabolite PNU142586. [PDF]
Sci AdvThu VTA, Nhu NQ, Anh NTV, Lim SA, Seong HJ, Md Rasheduzzaman J, Kim U, Cho HS, Soedarsono S, Shin JG, Cho YS. +10 moreeuropepmc +1 more sourceLarge-scale testing of antimicrobial lethality at single-cell resolution predicts mycobacterial infection outcomes. [PDF]
Nat MicrobiolJovanovic A, Bright FK, Sadeghi A, Wicki B, Caño Muñiz SE, Giannini GC, Toprak S, Sauteur L, Rodoni A, Wüst A, Lupien A, Borrell S, Grogono DM, Wheeler NE, Dehio P, Nemeth J, Pargger H, Thomson R, Bell SC, Gagneux S, Bryant JM, Peng T, Diacon AH, Floto RA, Abanto M, Boeck L. +25 moreeuropepmc +1 more sourceContribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis. [PDF]
Antimicrob Agents ChemotherEncinas L, Li S-Y, Rullas-Trincado J, Tasneen R, Tyagi S, Soni H, Garcia-Perez A, Lee J, González Del Río R, De Mercado J, Sousa V, Sosič I, Gobec S, Mendoza-Losana A, Converse PJ, Mdluli K, Fotouhi N, Barros-Aguirre D, Nuermberger EL. +18 moreeuropepmc +1 more source
